medigraphic.com

2014, Number 2

<< Back Next >>

Cir Cir 2014; 82 (2)

Platelet rich plasma versus oral paracetamol for the treatment of early knee osteoarthritis. Preliminar study

Acosta-Olivo C, Esponda-Colmenares F, Vilchez-Cavazos F, Lara-Arias J, Mendoza-Lemus O, Ramos-Morales T

Language: Spanish
References: 34
Page: 163-169
PDF size: 340.35 Kb.


ABSTRACT

Background: in the treatment of early osteoartrosis, analgesics and non-steroidal anti-inflammatory drugs are frequently used to relieve pain. Currently, platelet rich plasma is used as an alternative in the treatment of osteoartrosis. The aim of this study was to evaluate the effect of platelet rich plasma compared to paracetamol as a treatment for patients with knee osteoartrosis grade I.
Methods: we evaluated 42 patients who were randomized into two groups. Group one was treated with 5 mL of platelet rich plasma in two applications, while group two was treated with 1 gr of oral paracetamol every 8 hours for 30 days. Both patient groups received supervised physical rehabilitation during the 6 month observation period. Peripheral blood samples were taken to measure plasma IL-1β, TNF-α and TGF-β1 levels at day 0 and at 6 months post-treatment. Clinical evaluation was conducted using the KOOS at the start of the study and for every subsequent month during the study period.
Results: the Knee injury and Osteoarthritis Outcome Score (KOOS) for group one at the start of the treatment was measured at 30.1 points, whereas at the end, it was measured at 48.2 points, showing a clinical improvement of 60%. There were no statistically significant differences in IL-1β and TNF-α levels between groups treated either with platelet rich plasma or paracetamol.
Conclusions: Our patients treated with platelet rich plasma showed a statistically significant increase in the serum levels of TGF-β1, which was associated with an improvement in the clinical evaluation used (KOOS).


REFERENCES

  1. Felson D, Lawrence RC, Dieppe PA, Helmick CG, Jordan JM, Kington RS, et al. Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors. Ann Intern Med 2000;133:635- 646.

  2. Lanyon P, O´Reilly S, Jones A, Doherty M. Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis 1998;57:595-601.

  3. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly. The framingham study. Arthritis Rheum 1997;40:728-733.

  4. Lau E, Copper C, Lam D, Chan V, Tsang K, Sham A. Factors Associated with Osteoarthritis of the Hip and Knee in Hong Kong Chinese: Obesity, Joint Injury and Occupational Activities. Am J Epidemiol 2000;152:855-862.

  5. Jüni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 2006;20(4):721-740.

  6. McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. Br J Rheumatol 1992;31:189-192.

  7. Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Care Rheum 2008;59:1207-1213.

  8. Michaëlsson K, Byberg L, Ahlbom A, Melhus H, Farahmand BY. Risk of Severe Knee and Hip Osteoarthritis in Relation to Level of Physical Excercise: A Prospective Cohort Study of Long-Distance Skiers in Sweden. PloS One 2011;6:e18339.

  9. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009;11:227.

  10. Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, et al. Cirulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010:18:1441-1447.

  11. Wassilew GI, Lehnigk U, Duda GN, Taylor WR, Matziolis G, Dynybil C. The Expression of Proinflammatory Cytokines and Matrix Metalloproteinase in the Sinovial Membranes of Patients With Osteoarthritis Compared With Traumatic Knee Disorders. Arthroscopy 2010;26:1096-1104.

  12. Goldberg VM, Goldberg L. Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis. J Pain Res 2010;3:51-56.

  13. Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, et al. A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate on sinovial joints with osteoarthritis. Eur J Phys Rehabil Med 2011;47:407-415.

  14. Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011;70:982-989.

  15. Richette P, Hilliquin P, Bertin P, Carni P, Berger V, Marty M. Comparison of general practitioners and rheumatologists´prescription patterns for patients with knee osteoarthritis. BMC Musculoskeletal Dis 2011;12:72.

  16. Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010;34:589-597.

  17. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis. 1957;16:494-501.

  18. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury and osteoarthritis outcome score (KOOS) - development of a self-administrated outcome measure. J Orthop Sports Phys Ther 1998;28:88-96.

  19. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis. A pilot study. Am J Phys Med Rehabil 2010;89:961-969.

  20. Redini F, Galera P, Mauviel A, Loyau G, Pujol J. Transforming growth factor ß stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 1988;234:172-176.

  21. Redini F, Daireaux M, Mauviel A, Galera P, Loyau G, Pujol JP. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-ß (TGF-ß). Biochim Biophys Acta 1991;1093:196-206.

  22. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-290.

  23. Anitua E, Sánchez M, de la Fuente M, Azofra J, Zalduendo M, Aguirre JJ, et al. Relationship between Investigative Biomarkers and Radiographic Grading in Patients with Knee Osteoarthritis. Int J Rheumatol 2009;747432. Disponible en http://dx.doi.org/10.1155/2009/747432

  24. Nelson AE, Golightly YM, Kraus VB, Stabler T, Renner JB, Helmick CG, et al. Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 2010;18:825-829.

  25. Dingle JT, Saklatvala J, Hembry R, Tyler J, Fell HB, Jubb R. A cartilage catabolic factor from synovium. Biochem J 1979;184:177-180.

  26. Shlopov B, Gumanovskaya ML, Hasty KA. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 2000;43:195-205.

  27. van der Kraan P, Blaney Davidson EN, van den Berg WB. A role for age-related changes in TGF-ß signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res Therapy 2010;12:201.

  28. van Buul GM, Koevoet WLM, Kops N, Bos PK, Verhaar JAN, Weinans H, et al. Platelet-Rich Plasma Releasete Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes. Am J Sport Med 2011;39:2362-2370.

  29. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002;39:237-246.

  30. Wu CC, Chen WH, Zao B, Lai PL, Lin TC, Lo HY, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 2011;32:5847-5854.

  31. McCarrel TM, Minas T, Fortier LA. Optimization of Leukocyte Concentration in Platelet-Rich Plasma for the Treatment of Tendinopathy. J Bone Joint Surg Am 2012;94:e143(1-8).

  32. Tate KS, Crane D. Platelet Rich Plasma Grafts In Musculoskeletal Medicine. J Prolotherapy 2010;2:371-376.

  33. Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning apporach. Knee Surg Sports Traumatol Arthrosc 2012;20:2082-2091.

  34. Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol 2013;23:573-580.




2020     |     www.medigraphic.com